Introduction Endacea, a biopharmaceutical company located in RTP, NC, is working on creating a line of exclusive A1 adenosine receptor (AR) antagonists to be used as medical treatments for conditions such as sepsis, asthma, and renal impairment. Additionally, Endacea has established a subsidiary called Endacea Diagnostics to create an endotoxin assay that can accurately detect sepsis and other related conditions. |